Novartis e Sanofi chiedono prezzi più elevati in Europa
https://www.swissinfo.ch/eng/multinational-companies/novartis-and-sanofi-call-for-higher-drug-prices/89203120
di BezugssystemCH1903
Novartis e Sanofi chiedono prezzi più elevati in Europa
https://www.swissinfo.ch/eng/multinational-companies/novartis-and-sanofi-call-for-higher-drug-prices/89203120
di BezugssystemCH1903
30 commenti
Article:
>__Swiss and French pharmaceutical companies Novartis and Sanofi are pushing for higher medicine prices in Europe.__
>In an open letter published on Wednesday in the UK’s Financial Times, they argued that the European Union (EU) should adjust its prices to better align with those in the United States.
>Higher prices stimulate innovation and encourage investment in the European pharmaceutical industry, said Novartis CEO Vas Narasimhan and Sanofi CEO Paul Hudson. They warned that the competitiveness of European pharmaceutical companies is declining, and uncertainties around customs duties are discouraging investment in the EU.
>__Declining investment in EU pharma__
>Low drug prices in the EU are stifling growth and making innovation less appealing, continued Narasimhan and Hudson. Amid threats of customs duties and increasing competition from China, the two executives are raising the alarm, predicting a decline in investment in Europe.
>The two CEOs urged the European Commission to set a spending target for medicines and vaccines, and to establish reference prices similar to the net prices in the US, adjusted with rebates where necessary. According to the US government, drug prices are nearly three times higher in the US than in comparable countries.
>Narasimhan and Hudson also criticised European bureaucracy and called for an end to national measures that cap market volume and to price cuts for new indications.
>In contrast, the US is seeing a surge in pharmaceutical industry investment. Novartis has announced plans to invest $23 billion (CHF19 billion) in production and research, while Roche aims to invest $50 billion over the next five years.
A minute of silence for those poor suffering pharma companies. I guess the CEOs don’t have enough private yachts right now, it’s a shame.
Why should we care if they make more profits, really how detached from reality can they be?
>In contrast, the US is seeing a surge in pharmaceutical industry investment.
Ah yes, the customers within the US famously benefit from this.
This will lead to:
-lowering of minimum thresholds to treat a disease
(like for familiar cholesterolaemia)
-A boom in Medical science liaisons (the new word for pharma representatives) positions
-increased burden on healthcare systems that are already under stress
-increased shareholder value
-minimal increase in product pipeline conversion
I don’t understand that. I thought drug companies negotiate prices with each individual country and not the EU (leading btw to some EU countries not receiving certain drugs). I also thought that these negotiated prices are largely non-public information, but we know that larger countries in general make better deals.
So, why is the EU mentioned here and can’t those drug companies simply try to negotiate higher prices if they really want to?
Ofcourse they are, the 500% profit is not enough in 2025! 🤦♂️
I’d rather use cheap generic medicines.
Big Pharma have raised this issue in Australia as well in regards to our PBS scheme in which they deal directly with the Govt in bulk for medicines.
They’ve become embolded because the robber barons that now form the US Govt will encourage them to set up shop in the USA so they can increase profits.
Innovation my ass.
About 20 years ago Novartis pushed Belgium to allow a 100% increase in price for methylphenidate, a medication where any R&D had by that time long since recovered. It´s aldo very cheap to produce and doesn´t need any marketing.
Allow me to laugh at those funny excuses.
One of the first thing Vas did when he replaces Joe as NVS CEO was to undo the commitment to the Euoprean manufacturing of bulk products but instead to put the focus on CGT (>€150 000 per administration).
His target (in 2018) was to produce 2000 batches per year in one production site. Until now they produced less than 4000. Meanwhile he sold almost all the facilities and is now renting it back (GETEC -the new owener- must laugh their asses of).
Bold move after the billions collected from Covid vaccines (which were a flop regarding these 2)
I don’t know if you’ve noticed, but there’s been a recent trend in Europe pushing for mergers and acquisitions to create “European giants” that can compete with global players like the U.S. and China.
Let’s say there are cases where it makes sense, because companies can become more productive and competitive. But beyond a certain point, it stops making sense
The problem is that, even with the European antitrust system, this reduces competition and leads to oligopolies. These companies don’t need explicit cartels, they can engage in tacit collusion, using their size to suppress competition and influence policy.
We’re shooting ourselves in the foot without realizing it
The answer would be not to give in and to impose counter-tariffs on the U.S. Otherwise, they’ll start producing there not just for their own market, but for ours too, weakening our industrial base
In theory, not reciprocating might seem like the right approach, but in practice, it’s difficult. The U.S. is so large and influential that it can distort global trade. When most countries impose tariffs, they harm themselves more. If the U.S. imposes tariffs, they harm both themselves and the world. In this case, if we don’t respond, we’ll lose more, while they’ll lose less. But if we do retaliate, at least we make it equal, or maybe they’ll bear more of the cost than us
Yes we totally copy the capitalist model of the US, it works well we can see that… Like they don t make enough money already… This people have no shame and no humanity left in them that s a certainty
And I call for Novartis and Sanofi to fuck off
This is a similar case to the Sony one: higher costs for Europeans bc of lower prices/investments forced by Trump.
If Europe doesn’t block this and fight against it, Europeans will greatly suffer from price increases in all areas bc of this Trump f*ckhead.
The title should read “Novartis and Sanofi call for higher profits in Europe”.
They should raise prices in the US to subsidize the EU market
Problem is the regulatory cost.
Developing the actual drug molecule costs some tens of millions of dollars. (Not counting many fails).
The actual clinical study and regulatory burden easily adds up to hundreds of millions of dollars though.
People want maximum safety, ethics, procedure: that’s the reason why it’s so expensive.
« Someone I know » lead preclinical in a new drug. Got bought for a billion dollar by big pharma. Passed phase 1 and 2 easily. Totally failed in phase 3.
Do that 3 times in a row, even Novartis goes bankrupt.
Drug development is extremely risky and expensive. I don’t think it could easily be another way.
Selling a treatment for mere hundreds will never make it worthwhile and innovation will just stop.
Nationalize them without compensation and fire and/or imprison those crooked CEO’s.
Yeh, you know what big pharma. Fuck you…sincerely.
Having once tasted the huge amount of easy money, as it was during Covid, it is impossible to resist the temptation to have such a financial flow always.
You mean they’re trying to pull a Sony?
Raise prices for USA. Profit.
Imagine being so absolutely clueless about the rest of the world so all that matters is your Swiss bank account, your jetset life and returns your shareholders make.
Where is Luigi when you need him?
Makes totally sense if the companies are not allowed to pay dividends or salary raises for the top management. And have to make sure margins are not expanded and all extra cash go into research…
But probably they wouldn’t go with that.
Water is wet. I mean of course they do since they are one of the largest pharma companies
as long as these people can’t figure out they have to share the money instead of constantly aasking for me, we’re not going to get better.
Friggen Swiss companies.
They are trying to offset their loss from the US on the EU.
Just like Sony.